Michael Soldan

Head of Biosimilars at Zentiva | Ex-Biotech CEO/Board | Scaling Biosimilar Adoption: Strategy • Access • Partnerships

Switzerland

About

Experienced Senior Vice President with a demonstrated history of working in the pharmaceuticals industry. Skilled in General Management, Clinical Research, Protein Chemistry, Life Sciences, Vaccines, and Oncology. Strong professional graduated from PhD.

Experience

  • Head of Biosimilars at Zentiva
    Sep 2025 - Present · 10 mos

    • Spearheaded the introduction of a comprehensive Biosimilar portfolio at Zentiva, enhancing market presence. • Cultivated strategic partnerships to optimize product launches and drive growth in various countries. • Collaborated with cross-functional teams to ensure alignment on portfolio strategies and execution.

  • Senior Consultant and Adviser at MSBiotechConsulting
    Apr 2024 - Sep 2025 · 1 yr 6 mos

    As a seasoned Senior Adviser, I leverage my extensive experience as a Biotech CEO and Board Member to catalyze success and foster innovation within the biotech industry. My mission is to empower biotech ventures with strategic insights, development expertise, and investment acumen. Whether it's providing tailored guidance on business strategy, offering astute investment advice, or mentoring the next generation of industry leaders, I am dedicated to driving tangible results for my clients. Let's collaborate to navigate the complexities of the biotech landscape and unlock the full potential of your endeavors.

  • Chief Executive Officer at Polpharma Biologics Group
    Dec 2021 - Apr 2024 · 2 yrs 5 mos

  • CEO at AB2 Bio
    Apr 2020 - Dec 2021 · 1 yr 9 mos

  • EVP Head of Biosimilars at Fresenius Kabi
    Sep 2017 - Apr 2020 · 2 yrs 8 mos